Key points from this week’s report:
Please refer to the attached PDF for the full report.
- The MSCI Asia Ex Japan index (AAXJ) declined below its 50-DMA and is 7% off highs. We recommend a cautious approach. Wait for major markets to follow through before increasing risk. Continue to reduce extended ideas. Focus on select ideas with rising relative strength that are holding above key moving averages, with improving industry group rank.
- Six markets, including India and Australia, are in a Confirmed Uptrend. The Philippines is in an Uptrend Under Pressure. Four markets, including Japan and Hong Kong, are in a Rally Attempt. China and Taiwan are in a Downtrend.
- Technology continues to remain in the top-right quadrant (Outperform/Improve) of the APAC Sector Rotation Graph. Health Care, which has been underperforming over a long period, has improved over the last four weeks. Refer to page.
- Rotation is occurring among Technology industry groups (IGs). Semi-Conductor and Hardware related IGs are lagging in Taiwan, South Korea, and Japan, while Tech Services is improving in Japan and India due to better-than-expected results, and positive commentary about the revival of IT spending.
- Based on median 3-month RS Rating, Health Care is leading, followed by Consumer Staple. Within Health Care, Medical-Generic Drugs and Medical-Ethical Drugs have outperformed over the last 13 weeks. Refer to page 9 for a list of leaders in Health Care. These stocks are trading above key moving averages with rising relative strength.
- Highlighted Focus List Idea: Samsung Biologics (BCS.KR; 207940 KS).